Aiming to develop an inexpensive and effective innovative angiogenesis therapy using cell therapy - Investigator-initiated clinical trial using a combination of autologous peripheral blood mononuclear cells and injectable cell scaffold (ICS-001) for patients with comprehensive chronic limb ischemia (CLTI) -